SAN DIEGO, Feb. 8, 2012 (GLOBE NEWSWIRE) -- MediciNova Inc, a biopharmaceutical company traded on the NASDAQ Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka Securities Exchange (4875), will be presenting at the 18th annual American Academy of Emergency Medicine (AAEM) scientific assembly at the Hotel Del Coronado, San Diego. Kazuko Matsuda, M.D., Ph.D, MPH, Chief Medical Officer of MediciNova, will provide an overview of current treatment practice in emergency departments for patients presenting with acute bronchospasms related to asthma or chronic obstructive pulmonary disease (COPD) and MediciNova's novel pharmacotherapy, MN-221, that MediciNova is developing to address currently unmet needs. The oral presentation will take place Thursday, February 9th at 3:30pm (PST), in the Spreckles A&B conference room.
